Syros Pharmaceuticals To Present New Data From Its Gene Control Platform In AML And Breast Cancer At American Association for Cancer Research Annual Meeting 2015
WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a therapeutics company focused on discovering and developing novel gene control therapies, announced today that it will present two posters at the American Association for Cancer Research (AACR) Annual Meeting 2015 in Philadelphia, which begins April 18.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.